Trademarkia Logo

Canada

C$
REKRUZIQ
APPROVED

on 14 Apr 2025

Last Applicant/ Owned by

Checkpoint Therapeutics, Inc.

95 Sawyer Rd, Ste 110Waltham, MA 02453

US

Serial Number

2214072 filed on 6th Oct 2022

Correspondent Address

MARKS & CLERK

33 Yonge Street, Suite 300Toronto

ONTARIO

CA

M5E1G4

REKRUZIQ

Trademark usage description

pharmaceutical preparations for use in the treatment of cancer

Classification Information


Class [005]
Pharmaceutical preparations for use in the treatment of cancer


Classification kind code

11

Mark Details


Serial Number

2214072

Mark Type

Trademark

Legal History


Action TakenStatus
Submitted for opposition 26
on 14th Apr 2025
Approved
Submitted for opposition 27
on 14th Apr 2025
Approval Notice Sent
Submitted for opposition 22
on 4th Apr 2025
Search Recorded
Submitted for opposition 287
on 13th Oct 2022
Pre-Assessment Letter Sent
Submitted for opposition 30
on 6th Oct 2022
Filed
Submitted for opposition 1
on 6th Oct 2022
Created
Submitted for opposition 31
on 6th Oct 2022
Formalized